Cargando…

O027 A randomised dose finding study of combination dronabinol and acetazolamide for the treatment of obstructive sleep apnoea: A proof of concept study

INTRODUCTION: Current treatments for obstructive sleep apnoea (OSA) are not tolerated or effective in a proportion of patients. Other therapeutic options are needed; pharmaceuticals may provide an alternative. This randomised, double-blind, placebo-controlled, cross-over study examined the effect of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Walsh, J, Rankin, T, Mehra, S, Naughton, M, Roebuck, T, McDermott, E, Pattichis, A, Smith, R, Germaine, J, Walsh, R, Bleackley, M, Maddison, K, O'Brien, T
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	ORAL PRESENTATIONS
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10109426/ http://dx.doi.org/10.1093/sleepadvances/zpac029.026

Ejemplares similares

O027 Patterns of nocturnal swallow frequency and related tachycardia with sleep stages and obstructive sleep apnoea severity
por: Lin, A, et al.
Publicado: (2023)

Proof of Concept Trial of Dronabinol in Obstructive Sleep Apnea
por: Prasad, Bharati, et al.
Publicado: (2013)

Bioavailability study of dronabinol oral solution versus dronabinol capsules in healthy volunteers
por: Parikh, Neha, et al.
Publicado: (2016)

O071 The performance accuracy of wrist-worn oximetry and its automated output parameters for screening obstructive sleep apnoea in children
por: Ohn, M, et al.
Publicado: (2022)

Effect of food on the pharmacokinetics of dronabinol oral solution versus dronabinol capsules in healthy volunteers
por: Oh, D Alexander, et al.
Publicado: (2017)

O009 Are there Differences in SpO2 Recordings from Two Oximeters on the same hand during an Overnight Sleep Study Significant?
por: McDermott, E, et al.
Publicado: (2023)

P027 Predictors of CPAP failure in severe obstructive sleep apnoea and obesity hypoventilation syndrome patients
por: Chen, K, et al.
Publicado: (2022)

Acetazolamide affects Aquaporin 1 expression of cultured choroid plexus cells
por: Pattisapu, Jogi V, et al.
Publicado: (2010)

P027 Early warning bells: emergence of fluconazole resistance in Candida parapsilosis
por: Ajapuje, Preeti
Publicado: (2022)

Treatment‐emergent central sleep apnoea managed by CPAP with adjunctive acetazolamide: A case report
por: Kwok, Chin Tong, et al.
Publicado: (2022)

O022 Long-term cardiovascular risk in obstructive sleep apnoea: a sleep clinic cohort study
por: Shenoy, B, et al.
Publicado: (2021)

Dronabinol for chemotherapy-induced nausea and vomiting unresponsive to antiemetics
por: May, Megan Brafford, et al.
Publicado: (2016)

O006 Major adverse cardiovascular events in severe Obstructive Sleep Apnoea: Associations with symptom subtypes and symptom burden
por: Shenoy, B, et al.
Publicado: (2023)

O027: Compliance of jordanian registered nurses with infection control guidelines: a national population-based study
por: Al-Rawajfah, OM, et al.
Publicado: (2013)

The successful use of dronabinol for failure to thrive secondary to intestinal dysmotility
por: Taylor, Grace H., et al.
Publicado: (2015)

Case Report: Secondary bilateral parkinsonism and dystonia treated with dronabinol
por: Szejko, Natalia, et al.
Publicado: (2021)

Hypoventilation and sleep apnoea in spina bifida - an unrecognised problem?
por: Hillan, Josephine, et al.
Publicado: (2009)

O056 The effect of acetazolamide and oxygen (ACZ+O2) combination therapy on loop gain and OSA severity
por: Landry, S, et al.
Publicado: (2022)

O027. Sub-cortical sources of the somatosensory pathway are hypoactive in migraine interictally: a Functional Source Separation analysis
por: Porcaro, Camillo, et al.
Publicado: (2015)

O027 The combination of mandibular advancement devices (MAD) and supplemental oxygen dramatically improves OSA severity: preliminary results from the MADOX trial
por: Edwards, B, et al.
Publicado: (2021)

Effect of acetazolamide on obstructive sleep apnoea in highlanders: protocol for a randomised, placebo-controlled, double-blinded crossover trial
por: Tan, Lu, et al.
Publicado: (2022)

Fever, fear and hunger: the response of the Irish population to infectious disease during the Great Irish Famine, 1845-48
por: McDermott, R
Publicado: (2012)

P074 Three models of pulse oximeters are within specifications when assessed using a benchtop pulse oximeter simulator
por: McDermott, E, et al.
Publicado: (2022)

Clinical utility of dronabinol in the treatment of weight loss associated with HIV and AIDS
por: Badowski, Melissa E, et al.
Publicado: (2016)

Dronabinol oral solution in the management of anorexia and weight loss in AIDS and cancer
por: Badowski, Melissa E, et al.
Publicado: (2018)

O058 Are short central apnoeas in preterm infants really benign? Effects on cardiovascular control.
por: Yee, A, et al.
Publicado: (2023)

O004 Obstructive sleep apnoea severity is associated with parasympathetic withdrawal in coronary artery disease
por: Ucak, S, et al.
Publicado: (2021)

The Safety of Dronabinol and Nabilone: A Systematic Review and Meta-Analysis of Clinical Trials
por: Bajtel, Ákos, et al.
Publicado: (2022)

DMSO potentiates the suppressive effect of dronabinol on sleep apnea and REM sleep in rats
por: Calik, Michael W., et al.
Publicado: (2023)

O039 A Novel Approach to Quantify Breathing effort in Obstructive Sleep Apnoea
por: Nguyen, P, et al.
Publicado: (2023)

O011 Effect of Continuous Positive Airway Pressure on Quality of Life and Treatment Burden in Children with Obstructive Sleep Apnoea
por: Nisbet, L, et al.
Publicado: (2022)

O022 Characteristics of patients with obstructive sleep apnoea with a focus on the First Nations population
por: Bolger, M, et al.
Publicado: (2023)

O017 Real-World Utility of Overnight Oximetry for the Screening of Obstructive Sleep Apnoea in Children
por: Hartnett, C, et al.
Publicado: (2023)

O048 Why don’t Australians with Private Health Insurance Prioritise their Sleep Health?
por: Sweet, A, et al.
Publicado: (2023)

O018 Improvement in Obstructive Sleep Apnoea Improves Heart Rate response to Obstructive Respiratory events in Children with Down syndrome.
por: Walter, L, et al.
Publicado: (2023)

O013 The pathogenesis of obstructive sleep apnea in individuals with comorbid insomnia and obstructive sleep apnoea (COMISA)
por: Brooker, E, et al.
Publicado: (2021)

O008 The effect of flow limited breathing and endotypes on night to night variability of sleep apnoea severity
por: Hynes, D, et al.
Publicado: (2022)

O036 Respiratory event related oxygen desaturation is predictive of cardiovascular mortality in sleep apnoea patients
por: de Chazal, P, et al.
Publicado: (2021)

O054 What Measure of CPAP Treatment is most closely Associated with Reduced Risk of Future Major Cardiovascular Events (MACE)?
por: Reynor, A, et al.
Publicado: (2023)

O052 Association of co-morbid insomnia and sleep apnoea (COMISA) symptoms with all-cause mortality: Analysis of the NHANES 2005-2008 data
por: Sweetman, A, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_kjej9r4sugajtpma1t6j4gakn0